Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine

被引：0
|
作者：
Joan Manel Gasent Blesa
Vicente Alberola Candel
Mariano Provencio Pulla
Emilio Esteban González
Salvador Martín Algarra
机构：
[1] Hospital de Dènia Marina Salud,Medical Oncology Department
[2] Hospital Universitari Arnau de Vilanova,Medical Oncology Department
[3] Hospital Universitario Puerta de Hierro,Medical Oncology Department
[4] Hospital Universitario Central de Asturias,Medical Oncology Department
[5] Clínica Universitaria de Pamplona Pamplona,Medical Oncology Department
来源：
Clinical and Translational Oncology | 2009年 / 11卷
关键词：
Ovarian cancer; Platinum-resistant; Pemetrexed-Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：35 / 40
页数：5
相关论文
共 50 条
  • [1] Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine
    Gasent Blesa, Joan Manel
    Alberola Candel, Vicente
    Provencio Pulla, Mariano
    Esteban Gonzalez, Emilio
    Martin Algarra, Salvador
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 35 - 40
  • [2] Gemcitabine and anthracyclines in platinum-resistant ovarian cancer
    Galligioni, E.
    Arcuri, C.
    Sorio, R.
    Griso, C.
    ANNALS OF ONCOLOGY, 2006, 17 : V195 - V198
  • [3] Activity of gemcitabine in platinum-resistant ovarian germ cell cancer
    Maas, K
    Daikeler, T
    Kanz, L
    Bokemeyer, C
    EUROPEAN JOURNAL OF CANCER, 1996, 32A (08) : 1437 - 1438
  • [4] The use of treosulfan and gemcitabine in the treatment of platinum-resistant ovarian cancer
    Hilman, S.
    Koh, P. K.
    Collins, S.
    Allerton, R.
    ONCOLOGY LETTERS, 2010, 1 (01) : 209 - 213
  • [5] Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer
    Niu, J.
    Kundranda, M. N.
    Markman, M.
    Farley, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2017, 38 (01) : 40 - 44
  • [6] Review of gemcitabine-based combinations for platinum-resistant ovarian cancer
    Sehouli, J
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 : 23 - 30
  • [7] Platinum-resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine
    Komiyama, Shinichi
    Kugimiya, Tsuyoki
    Takeya, Chiaki
    Takahashi, Rena
    Kubushiro, Kaneyuki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (07) : 1330 - 1334
  • [8] The outcome of patients with platinum-resistant/refractory ovarian cancer treated with the combination of pegylated liposomal doxorubicin and gemcitabine
    Galic, V.
    Boulay, R.
    Thomas, M.
    Miller, R.
    Gillenwater, C.
    Chen, C.
    Martino, M.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S48 - S48
  • [9] Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
    R. Wendel Naumann
    Robert L. Coleman
    Drugs, 2011, 71 : 1397 - 1412
  • [10] Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
    Naumann, R. Wendel
    Coleman, Robert L.
    DRUGS, 2011, 71 (11) : 1397 - 1412
12345